Pharma & Biotech

The German biotechnology firm Evotec SE finds itself at a critical juncture, marked by a significant clinical milestone that starkly...

The Canadian cannabis sector witnessed a significant consolidation on March 16, 2026, as Canopy Growth Corporation finalized its takeover of...

The biotechnology firm BioNxt Solutions continues to announce the kind of progress that typically attracts investor interest: new patents and...

Investors in Formycon are currently facing a contradictory set of developments. The stock price plunged to a new 52-week low...

In the specialized markets for cannabis and psychedelics, Hytn Innovations is pursuing a distinct strategy: adhering to stringent pharmaceutical-grade standards....

For investors seeking growth, the global healthcare sector continues to present compelling opportunities. The Polar Capital Global Healthcare investment trust...

The future trajectory of BioNTech SE is becoming increasingly tied to a single, promising oncology asset. The company’s ambitious cancer...

Ocugen, Inc. has bolstered its balance sheet without initiating a new formal funding round. The capital infusion came via the...

Positive early-stage clinical data for its immunotherapy drug Anktiva, presented by the company's founder, provided a pre-market lift to ImmunityBio...

A significant update to U.S. cancer treatment protocols has substantially broadened the potential patient population for ImmunityBio's flagship immunotherapy. The...